RAPP Competitors & Alternatives
Compare Rapport Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
RAPP
Main Stock$25.85
Tradestie Score
48
Market Cap
$1.32B
Analyst Upside
+148.4%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLDX
Celldex Therapeutics, Inc
|
$28.53
|
$1.68B | - | 49 | Compare |
|
MNKD
Mannkind Corporation
|
$4.16
|
$1.65B | - | 32 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$45.82
|
$1.63B | 5.7 | 37 | Compare |
|
BHVN
Biohaven Ltd.
|
$14.07
|
$1.57B | - | 41 | Compare |
|
VCEL
Vericel Corporation
|
$57.42
|
$1.56B | 92.9 | 32 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$92.48
|
$1.55B | - | 41 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$33.80
|
$1.55B | 11.3 | 61 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$33.83
|
$1.55B | - | 44 | Compare |
|
NVAX
Novavax Inc
|
$8.76
|
$1.54B | - | 57 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$16.21
|
$1.50B | 7.1 | 54 | Compare |
More RAPP Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry